These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18490644)

  • 21. Has National Colorectal Cancer Awareness Month increased endoscopy screening rates and public interest in colorectal cancer?
    Pantel HJ; Kleiman DA; Kuhnen AH; Marcello PW; Stafford C; Ricciardi R
    Surg Endosc; 2021 Jan; 35(1):398-405. PubMed ID: 32016518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer screening: is earlier better?
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):519. PubMed ID: 30047441
    [No Abstract]   [Full Text] [Related]  

  • 23. 2017 Emily Couric Memorial Lecture: Colorectal Cancer: Polyps, Prevention, and Progress.
    Pochapin MB
    Am J Gastroenterol; 2018 Dec; 113(12):1772-1777. PubMed ID: 29997398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-specific prevalence of adenomas and colorectal cancer.
    Roy HK; Bianchi LK
    JAMA; 2012 Jan; 307(2):142; author reply 143-4. PubMed ID: 22235076
    [No Abstract]   [Full Text] [Related]  

  • 25. Sex-specific prevalence of adenomas and colorectal cancer.
    Hoffmeister M; Brenner H
    JAMA; 2012 Jan; 307(2):142-3; author reply 143-4. PubMed ID: 22235077
    [No Abstract]   [Full Text] [Related]  

  • 26. ASGE guideline: colorectal cancer screening and surveillance.
    Davila RE; Rajan E; Baron TH; Adler DG; Egan JV; Faigel DO; Gan SI; Hirota WK; Leighton JA; Lichtenstein D; Qureshi WA; Shen B; Zuckerman MJ; VanGuilder T; Fanelli RD;
    Gastrointest Endosc; 2006 Apr; 63(4):546-57. PubMed ID: 16564851
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence of elevated colorectal cancer and adenoma rates for regional National Bowel Cancer Screening Program participants.
    Versace VL; Forsyth AD; Vaughan R; Morrice MG; Morphett BJ
    Aust J Rural Health; 2018 Feb; 26(1):63-64. PubMed ID: 28776860
    [No Abstract]   [Full Text] [Related]  

  • 28. Colorectal Cancer Screening Decisions in the Opportunistic Setting.
    Han A; Maratt J; Kahi C
    Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):413-422. PubMed ID: 32439079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonoscopy and Sigmoidoscopy Use among the Average-Risk Population for Colorectal Cancer: A Systematic Review and Trend Analysis.
    Cardoso R; Niedermaier T; Chen C; Hoffmeister M; Brenner H
    Cancer Prev Res (Phila); 2019 Sep; 12(9):617-630. PubMed ID: 31289028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).
    Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB
    Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer screening reduces incidence, mortality and morbidity.
    Jideh B; Bourke MJ
    Med J Aust; 2018 Jun; 208(11):483-484. PubMed ID: 29902408
    [No Abstract]   [Full Text] [Related]  

  • 32. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
    Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
    Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.
    Steinwachs D; Allen JD; Barlow WE; Duncan RP; Egede LE; Friedman LS; Keating NL; Kim P; Lave JR; Laveist TA; Ness RB; Optican RJ; Virnig BA
    Ann Intern Med; 2010 May; 152(10):663-7. PubMed ID: 20388702
    [No Abstract]   [Full Text] [Related]  

  • 34. Canadian Colorectal Cancer Screening Guidelines: Do They Need an Update Given Changing Incidence and Global Practice Patterns?
    Kalyta A; De Vera MA; Peacock S; Telford JJ; Brown CJ; Donnellan F; Gill S; Loree JM
    Curr Oncol; 2021 Apr; 28(3):1558-1570. PubMed ID: 33919428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer testing in Canada--2008.
    Wilkins K; Shields M
    Health Rep; 2009 Sep; 20(3):21-30. PubMed ID: 19813436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physician-patient communication regarding colorectal cancer screening is lacking.
    Barton MK
    CA Cancer J Clin; 2012; 62(1):1-2. PubMed ID: 22095204
    [No Abstract]   [Full Text] [Related]  

  • 37. Colorectal cancer screening patterns after the American Cancer Society's recommendation to initiate screening at age 45 years.
    Fedewa SA; Siegel RL; Goding Sauer A; Bandi P; Jemal A
    Cancer; 2020 Mar; 126(6):1351-1353. PubMed ID: 31850529
    [No Abstract]   [Full Text] [Related]  

  • 38. United States Preventive Services Task Force recommendations: age to end screening misunderstood.
    Zauber AG; van Ballegooijen M; Petitti D; Lansdorp-Vogelaar I
    Dis Colon Rectum; 2010 Oct; 53(10):1453; author reply 1453. PubMed ID: 20847630
    [No Abstract]   [Full Text] [Related]  

  • 39. From Colorectal Cancer Screening Guidelines to Headlines: Beware!
    Bretthauer M; Kalager M; Weinberg DS
    Ann Intern Med; 2018 Sep; 169(6):405-406. PubMed ID: 29987330
    [No Abstract]   [Full Text] [Related]  

  • 40. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.
    Bond JH
    Am J Gastroenterol; 2006 Feb; 101(2):219-21. PubMed ID: 16454821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.